Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
VBCC Perspectives
The NCCN New Tool to Assess Value Discourages Patients’ Hope
By
Robert Goldberg, PhD
Value-Based Care
,
VBCC Perspectives
November 2015, Vol 6, No 10
In October, the National Comprehensive Cancer Network (NCCN) released its first set of “flash cards” or “Evidence Blocks” as a tool for evaluating treatment decisions, seeking to solve a drug cost problem that does not exist, by adding to a problem that does: insurers shifting the cost of cancer treatment to patients. In so doing, the NCCN could inadvertently increase the rate at which patients with cancer choose assisted suicide.
Read Article
AstraZeneca Commentary on Oncology Value Tools
By
Diane Sullivan
Economics & Value
,
Value-Based Care
,
VBCC Perspectives
October 2015, Vol 6, No 9
As patients, providers, payers, and policymakers continue to seek ways to assess the value of cancer therapies by balancing clinical benefits and treatment costs, a number of tools have been released to define the value of medicines.
Read Article
The Missing Elements in Our Value-Based Care Discussions
By
Kevin Cast
Economics & Value
,
Value-Based Care
,
VBCC Perspectives
August 2015, Vol 6, No 7
Although we all admire and support the efforts put forth by many experts to help quantify the “real” value of cancer medications, they still miss the mark in 2 dramatic ways.
Read Article
Addressing the Value of New Cancer Treatment Options Using the ASCO Model
By
Philip E. Johnson, MS, RPh, FASHP
Economics & Value
,
Value-Based Care
,
VBCC Perspectives
August 2015, Vol 6, No 7
How can cancer care decisions be based on value? Two champions are starting to add science to this controversial discussion, which will eventually help all stakeholders make more informed decisions.
Read Article
ASCO’s Net Health Benefit: A Palliative Care Regimen Scores Higher than Active Treatment
By
Pamela Pelizzari, MPH
;
Bruce S. Pyenson, FSA, MAAA
Economics & Value
,
Value-Based Care
,
VBCC Perspectives
August 2015, Vol 6, No 7
Medicare’s Oncology Care Model (OCM) proposes a partial shift in financial risk from Medicare to oncologists. This incentivizes oncologists to use higher-value, lower-cost services. Information such as the recently released American Society of Clinical Oncology (ASCO) framework to assess new cancer treatment options will likely garner keen interest among providers participating in the OCM or similar programs, to the benefit of providers, payers, and patients.
Read Article
ASCO’s Value Framework Promoting Accountability and Transparency
By
Joseph Morse
Economics & Value
,
Value-Based Care
,
VBCC Perspectives
,
ASCO’s Value Framework
August 2015, Vol 6, No 7
The American Society of Clinical Oncology (ASCO) value framework essentially calls for accountability and transparency, which are qualities that are beneficial to providing complete care for patients and to improving positive patient outcomes.
Read Article
Emerging Tools for Assessing Value: Pros and Cons
By
Kirby J. Eng, RPh
Economics & Value
,
Value-Based Care
,
VBCC Perspectives
August 2015, Vol 6, No 7
The emergence of various tools for assessing value or, more to the point, drug costs—both direct and indirect—by leaders within the oncology and hematology community is highly commendable. Those of us on the managed care side of healthcare look forward to practical and meaningful tools in helping patients, providers, employers, and health plans navigate through the complexity of oncology drug therapy and drive better informed decision-making.
Read Article
Value-Based Oncology: The Intersection of Drug Costs, Effectiveness, and Toxicity
By
Roy Beveridge, MD
;
William K. Fleming, PharmD
;
Bryan Loy, MD, MBA
Economics & Value
,
Value-Based Care
,
VBCC Perspectives
July 2015, Vol 6, No 6
Value-based oncology was one of the high-profile topics at the 2015 American Society of Clinical Oncology (ASCO) meeting. It is something that is discussed widely in print and on social media. It is certainly top of mind for payers, doctors, policymakers, business leaders, and, in particular, patients.
Read Article
ASCO Value Framework: A Step Forward or Back?
By
Ted Okon, MBA
ASCO’s Value Framework
,
VBCC Perspectives
,
Economics & Value
,
Value-Based Care
July 2015, Vol 6, No 6
With all the focus in the media on cancer drug costs, let alone within the oncology community, the American Society of Clinical Oncology (ASCO) has released its much-anticipated value framework.
Read Article
Value-Based Oncology—A Specialty Pharmacy View
By
Bill D. Martin
VBCC Perspectives
,
Economics & Value
,
Value-Based Care
July 2015, Vol 6, No 6
Value versus cost is becoming an increasingly common question, particularly when evaluating new cancer drugs. The American Society of Clinical Oncology recently published its initial value framework to assist in assessing the value of new cancer therapies.
Read Article
Page 1 of 5
1
2
3
4
5
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma